EQUITY

6 Months Ended

12 Months Ended

Jun. 30, 2023

Dec. 31, 2022

Equity

EQUITY

19. EQUITY

(a) Issued capital

	December 31,		June 30,
	2022		2023		2023
	CNY		CNY		US$
	(Audited)		(Unaudited)		(Unaudited)
Authorized:
10,000,000 preferred shares, no par value		—		—		—
200,000,000 common shares, no par value		—		—		—
Common shares issued and fully paid:
June 30, 2023: 8,197,897*, (December 31, 2022: 40,948,082) common shares, no par value		450,782		450,782		62,146

	Number of shares			Share capital
				CNY		US$
As of January 1, 2022		40,948,082			450,782		62,146
Common shares issued through private placement		—			—		—
As of December 31, 2022 and January 1, 2023		40,948,082			450,782		62,146
Effect of Five-to-One Share Combination*		(32,750,185	)		—		—
As of June 30, 2023		8,197,897			450,782		62,146

* On April 3, 2023, the Company effected a share combination in which all of the Company's issued and outstanding ordinary shares were combined on a 5-to-1 basis. The basic and diluted earnings/(loss) per ordinary share has been retrospectively adjusted to reflect the impact of the share combination. All outstanding options, warrants and other rights to purchase the Company's common shares were adjusted proportionately as a result of the share combination.

(b) Other capital reserves

Other capital reserves of the Company are mainly for equity-settled share-based compensation, the exercise of stock options, the exercise of warrants, the business combination and the deemed contribution from the Shareholder of the Company and related companies.

25. EQUITY

(a) Issued capital

	December 31,
	2021		2022		2022
	CNY		CNY		US$
Authorized:
10,000,000 preferred shares, no par value		—		—		—
200,000,000 common shares, no par value		—		—		—
Common shares issued and fully paid:
December 31, 2022: 40,948,082* (December 31, 2021: 40,948,082) common shares, no par value		450,782		450,782		65,351

* The numbers of common shares above are before giving effect to the Share Combination which became effective on April 3, 2023. Refer to Note 31 for further details. 

(b) Other capital reserves

	Other capital reserves
	CNY		US$
As of January 1, 2021	787,987		114,236
Deemed distribution to the controlling shareholder	(75,651	)	(10,967	)
Equity-settled share-based payment	2,311		335
Others	4,463		647
As of December 31, 2021	719,110		104,251
As of January 1, 2022	719,110		104,251
Equity inventive share-based payment (Note 27)	16,209		2,342
As of December 31, 2022	735,319		106,600

Other capital reserves of the Company are mainly for equity-settled share-based compensation, the exercise of stock options, the exercise of warrants, the business combination and the deemed contribution from the Shareholder and related companies.

(c) Dividend restrictions and reserves

Due to the Group's structure, the payment of dividends is subject to numerous controls imposed under PRC law, including foreign exchange control on the conversion of the local currency into U.S. dollars and other currencies.

In accordance with the relevant PRC regulations, appropriations of net income as reflected in its PRC statutory financial statements are to be allocated to each of the general reserve and enterprise expansion reserve, respectively, as determined by the resolution of the Board of Directors annually.